Finance

Lists
Why is PMVP up 16,78%?
Dive Deeper
PMVP:NASDAQ
PMV Pharmaceuticals Inc
1,67 $
+16,78%
(+0,24) 1D
1,66 $
-0,60% (-0,0100)
Pre-market
Closed: 30 սեպ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PMVP...
Open
1,44 $
High
1,72 $
Low
1,44 $
Mkt. cap
126,11 մլն
Avg. vol.
717,06 հզր
Volume
1,14 հզր
52-wk high
1,88 $
52-wk low
1,02 $
EPS
-1,41 $
Beta
1,37
Shares outstanding
75,51 մլն
No. of employees
54
Open
1,44 $
High
1,72 $
Low
1,44 $
Mkt. cap
126,11 մլն
Avg. vol.
717,06 հզր
Volume
1,14 հզր
52-wk high
1,88 $
52-wk low
1,02 $
EPS
-1,41 $
Beta
1,37
Shares outstanding
75,51 մլն
No. of employees
54
News stories
From web sources and news partners
About PMV Pharmaceuticals Inc
CEO-
Employees54
Founded2013
Headquarters-
Sector-
Websitepmvpharma.com
Analyst ratings
Based on 5 analysts giving stock ratings to PMVP in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for PMVP in the last 3 months.
Highest
Current 1,67 $
5,00 $ (+199,40%)
Average
4,20 $ (+151,50%)
Lowest
3,00 $ (+79,64%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert Burns
H.C. Wainwright
Buy
Reiterated
5,00 $
+199,4%
09/08/2026
Unknown Analyst
Craig-Hallum
Buy
Reiterated
4,00 $
+139,5%
09/01/2026
Jonathan Miller
Evercore ISI
Buy
Maintained
4,00 $
+139,5%
09/01/2026
Jay Olson
Oppenheimer
Buy
Reiterated
5,00 $
+199,4%
09/01/2026
Jeff Jones
Oppenheimer
Buy
Reiterated
5,00 $
+199,4%
09/01/2026
Unknown Analyst
Ladenburg Thalmann & Co.
Buy
Reiterated
3,00 $
+79,6%
08/17/2026
Rick Bienkowski
Ladenburg Thalmann & Co.
Buy
Reiterated
3,00 $
+79,6%
08/17/2026
Yaron Werber
TD Cowen
Buy
Maintained
-
-
05/12/2026
Albert Lowe
Craig-Hallum
Buy
Maintained
4,00 $
+139,5%
11/13/2025
Last report
14 օգս, 2026 թ.
Fiscal period
Q2 2026
EPS / Est. (USD)
-0,34 $ / -0,40 $
+15,00%beat
Revenue / Est. (USD)
- / 0,00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
18,21 մլն
15,83 մլն
15,33 մլն
14,68 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,31 մլն
3,42 մլն
3,69 մլն
4,20 մլն
Operating expense
22,52 մլն
19,24 մլն
19,02 մլն
18,88 մլն
Total operating expenses
22,52 մլն
19,24 մլն
19,02 մլն
18,88 մլն
Operating income
-22,52 մլն
-19,24 մլն
-19,02 մլն
-18,88 մլն
Other non operating income
-23,00 հզր
-1,00 հզր
1,00 հզր
10,00 հզր
EBT including unusual items
-21,06 մլն
-18,01 մլն
-18,04 մլն
-18,08 մլն
EBT excluding unusual items
-21,06 մլն
-18,01 մլն
-18,04 մլն
-18,08 մլն
Income tax expense
-6,00 հզր
26,00 հզր
-
3,00 հզր
Effective tax rate
0,03%
-0,14%
-
-0,02%
Other operating expenses
-
-
-
-
Net income
-21,06 մլն
-18,04 մլն
-18,04 մլն
-18,09 մլն
Net profit margin
-
-
-
-
Earnings per share
-0,40
-0,34
-0,34
-0,34
Interest and investment income
1,48 մլն
1,23 մլն
980,00 հզր
788,00 հզր
Interest expense
-
-
-
-
Net interest expenses
1,48 մլն
1,23 մլն
980,00 հզր
788,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-22,49 մլն
-19,21 մլն
-18,98 մլն
-18,86 մլն
Gain or loss from assets sale
-1,00 հզր
-
-
25,00 հզր
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps